Episode 7 - Trust, Translation, and Therapeutics: The Story of Complement Therapeutics

In the seventh episode of The Biotech Pulse, Forbion General Partner Dmitrij Hristodorov, PhD is joined by Daniela Couto, General Partner at BioGeneration Ventures (BGV), and Professor Dr. Simon Clark, co-founder of Complement Therapeutics. Together, they explore the dynamics of building biotech companies from academia, using Complement Therapeutics as a case study. The discussion provides a unique, triangulated perspective, blending scientific discovery, early-stage investment, and the critical role of tech transfer offices in translating academic innovation into therapeutic reality. Listeners will gain insight into how successful collaborations between academic founders and venture capital can enable transformative science to progress toward clinical application. The episode highlights the trust and mutual understanding required to navigate the challenges of company formation, licensing, team building, and fundraising. With practical advice for aspiring biotech entrepreneurs and stories from the founding journey of Complement Therapeutics, this episode offers both inspiration and strategic guidance for the next generation of biotech leaders.See omnystudio.com/listener for privacy information.